Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of ceftobiprole medocaril
versus a comparator in the treatment of patients with complicated Staphylococcus aureus
bacteremia.